134P Doxorubicin and olaparib (OLA) synergism in high-grade serous ovarian (HGOC) and triple-negative breast cancer (TNBC) cell lines with olaparib-resistance
A comparison of a T1 weighted 3D gradient-echo sequence with three different parallel imaging reduction factors, breath hold and free breathing, using a 32 channel coil at 1.5 T. A preliminary study
Comparación de una secuencia en 3D con eco de gradiente potenciada en T1 con 3 factores de reducción de imagen en paralelo diferentes, en apnea y respiración libre, utilizando una bobina de 32 canales a 1,5T. Estudio preliminar (Spanish; Castilian)
Secuencia de disparo único eco de gradiente en fase y fase opuesta con preparación de la magnetización: descripción y optimización de la técnica con equipo de 1,5T (Spanish; Castilian)
Is There an Adequate Therapeutic Approach to Thyroid Pathology in Patients with Down Syndrome?
Autorzy:
Murillo-Llorente MT; SONEV Research Group, School of Medicine and Health Sciences, Catholic University of Valencia San Vicente Mártir, C/Quevedo nº 2, 46001 Valencia, Spain. Pérez-Bermejo M; SONEV Research Group, School of Medicine and Health Sciences, Catholic University of Valencia San Vicente Mártir, C/Quevedo nº 2, 46001 Valencia, Spain. Llacer-HerediaV; School of Medicine and Health Sciences, Catholic University of Valencia San Vicente Mártir, C/Quevedo nº 2, 46001 Valencia, Spain. Tomás-Aguirre B; CS Serreria II, Down Syndrome Unit-Clínico-Malvarrosa Department, Social Pediatrics Workgroup SVP, 46022 Valencia, Spain. Valls-Arévalo A; CS Nazaret Valencia, Clínico-Malvarrosa Department, INCLIVA Nutrition Research Group, 46024 Valencia, Spain. Tomás-Aguirre F; School of Medicine and Health Sciences, Catholic University of Valencia San Vicente Mártir, C/Quevedo nº 2, 46001 Valencia, Spain.
Absence of the primary cilia formation gene Talpid3 impairs muscle stem cell function.
Autorzy:
Martinez-HerediaV; School of Biological Sciences, University of East Anglia, Norwich Research Park, Norwich, UK.; Barcelona Institute for Science & Technology, Center for Genome Regulation CRG, Dr Aiguader 88, 08003, Barcelona, Spain. Blackwell D; School of Biological Sciences, University of East Anglia, Norwich Research Park, Norwich, UK.; Alberta Children's Hospital Research Institute (ACHRI), University of Calgary, Calgary, AB, Canada. Sebastian S; School of Biological Sciences, University of East Anglia, Norwich Research Park, Norwich, UK.; Clinical Biotechnology Center, NHSBS, Bath, UK. Pearson T; School of Biological Sciences, University of East Anglia, Norwich Research Park, Norwich, UK. Mok GF; School of Biological Sciences, University of East Anglia, Norwich Research Park, Norwich, UK. Mincarelli L; The Earlham Institute, Norwich Research Park, Norwich, UK.; Wellcome Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Saffron Walden, CB10 1RQ, UK. Utting C; The Earlham Institute, Norwich Research Park, Norwich, UK. Folkes L; School of Biological Sciences, University of East Anglia, Norwich Research Park, Norwich, UK. Poeschl E; School of Biological Sciences, University of East Anglia, Norwich Research Park, Norwich, UK. Macaulay I; The Earlham Institute, Norwich Research Park, Norwich, UK. Mayer U; School of Biological Sciences, University of East Anglia, Norwich Research Park, Norwich, UK. . Münsterberg A; School of Biological Sciences, University of East Anglia, Norwich Research Park, Norwich, UK. .
Pokaż więcej
Źródło:
Communications biology [Commun Biol] 2023 Nov 04; Vol. 6 (1), pp. 1121. Date of Electronic Publication: 2023 Nov 04.
Recombinant production of a functional SARS-CoV-2 spike receptor binding domain in the green algae Chlamydomonas reinhardtii.
Autorzy:
Berndt AJ; Division of Biological Sciences, University of California San Diego, La Jolla, California, United States of America. Smalley TN; Division of Biological Sciences, University of California San Diego, La Jolla, California, United States of America. Ren B; Division of Biological Sciences, University of California San Diego, La Jolla, California, United States of America. Simkovsky R; Division of Biological Sciences, University of California San Diego, La Jolla, California, United States of America. Badary A; Division of Biological Sciences, University of California San Diego, La Jolla, California, United States of America. Sproles AE; Division of Biological Sciences, University of California San Diego, La Jolla, California, United States of America. Fields FJ; Division of Biological Sciences, University of California San Diego, La Jolla, California, United States of America. Torres-Tiji Y; Division of Biological Sciences, University of California San Diego, La Jolla, California, United States of America. HerediaV; Division of Biological Sciences, University of California San Diego, La Jolla, California, United States of America. Mayfield SP; Division of Biological Sciences, University of California San Diego, La Jolla, California, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 Nov 18; Vol. 16 (11), pp. e0257089. Date of Electronic Publication: 2021 Nov 18 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
Enhanced bioproduction of anticancer precursor vindoline by yeast cell factories.
Autorzy:
Kulagina N; Université de Tours, EA2106 Biomolécules et Biotechnologies Végétales, Tours, France. Guirimand G; Université de Tours, EA2106 Biomolécules et Biotechnologies Végétales, Tours, France.; Graduate School of Sciences, Technology and Innovation, Kobe University, Kobe, Japan.; Le Studium Loire Valley Institute for Advanced Studies, Orléans & Tours, France. Melin C; Université de Tours, EA2106 Biomolécules et Biotechnologies Végétales, Tours, France. Lemos-Cruz P; Université de Tours, EA2106 Biomolécules et Biotechnologies Végétales, Tours, France. Carqueijeiro I; Université de Tours, EA2106 Biomolécules et Biotechnologies Végétales, Tours, France. De Craene JO; Université de Tours, EA2106 Biomolécules et Biotechnologies Végétales, Tours, France. Oudin A; Université de Tours, EA2106 Biomolécules et Biotechnologies Végétales, Tours, France. HerediaV; Université de Tours, EA2106 Biomolécules et Biotechnologies Végétales, Tours, France. Koudounas K; Université de Tours, EA2106 Biomolécules et Biotechnologies Végétales, Tours, France. Unlubayir M; Université de Tours, EA2106 Biomolécules et Biotechnologies Végétales, Tours, France. Lanoue A; Université de Tours, EA2106 Biomolécules et Biotechnologies Végétales, Tours, France. Imbault N; Université de Tours, EA2106 Biomolécules et Biotechnologies Végétales, Tours, France. St-Pierre B; Université de Tours, EA2106 Biomolécules et Biotechnologies Végétales, Tours, France. Papon N; Université d'Angers, EA3142 Groupe d'Etude des Interactions Hôte-Pathogène, Angers, France. Clastre M; Université de Tours, EA2106 Biomolécules et Biotechnologies Végétales, Tours, France. Giglioli-Guivarc'h N; Université de Tours, EA2106 Biomolécules et Biotechnologies Végétales, Tours, France. Marc J; Université de Tours, EA2106 Biomolécules et Biotechnologies Végétales, Tours, France. Besseau S; Université de Tours, EA2106 Biomolécules et Biotechnologies Végétales, Tours, France. Courdavault V; Université de Tours, EA2106 Biomolécules et Biotechnologies Végétales, Tours, France.
Pokaż więcej
Źródło:
Microbial biotechnology [Microb Biotechnol] 2021 Nov; Vol. 14 (6), pp. 2693-2699. Date of Electronic Publication: 2021 Jul 24.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
